A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma. Ann Surg Oncol 2023 Feb;30(2):688-690
Date
11/26/2022Pubmed ID
36427115Pubmed Central ID
PMC10688344DOI
10.1245/s10434-022-12742-3Scopus ID
2-s2.0-85145451354 (requires institutional sign-in at Scopus site) 4 CitationsAuthor List
Saif A, Verbus E, Erickson B, Kamgar M, Tsai S, Evans D, Hernandez JM, Hall WAAuthors
Beth A. Erickson MD Professor in the Radiation Oncology department at Medical College of WisconsinDouglas B. Evans MD Professor in the Surgery department at Medical College of Wisconsin
William Adrian Hall MD Chair, Professor in the Radiation Oncology department at Medical College of Wisconsin
Mandana Kamgar MPH, MD Associate Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdenocarcinomaAntineoplastic Combined Chemotherapy Protocols
Fluorouracil
Humans
Neoadjuvant Therapy
Pancreatic Neoplasms
Radiosurgery









